GL1X · GenesisL1 explorer

Research workbench

8QU8: PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1

Analyse 8QU8: PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8QU8
Type
protein
Length
1,325 residues
Chains
6
Method
electron microscopy
Authors
Fischer, G., Peter, D., Arce-Solano, S.
Deposited
10/14/23
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
3.5
Source
Homo sapiens
Molecule
von Hippel-Lindau disease tumor suppressor; Elongin-B; Elongin-C; Cullin-2; E3…
EC
3.6.5.2
UniProt
P40337, Q15370, Q15369, Q13617, P62877, P01116
Ligands
GDP, WYL, ZN
Pockets
20 · best druggability 0.81

Structure

electron microscopy · resolution 3.5 · 6 distinct chains · 45% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
Avon Hippel-Lindau disease tumor suppressorprotein13918% helix, 25% strandP40337
BElongin-Bprotein10318% helix, 25% strandQ15370
CElongin-Cprotein9644% helix, 13% strandQ15369
DCullin-2protein72960% helix, 1% strandQ13617
EE3 ubiquitin-protein ligase RBX1, N-terminally processedprotein8814% helix, 11% strandP62877
FGTPase KRas (EC 3.6.5.2)protein17037% helix, 26% strandP01116

Ligands and binding sites

  • GDP · Guanosine-5'-diphosphate · ligand · chains F
  • WYL · (2S,4R)-1-[(2S)-2-[4-[4-[(3S)-4-[4-[5-[(4S)-2-azanyl-3-cyano-4-methyl-6,7-dihydro-5H-1-benzothiophen-4-yl]-1,2,4-oxadiazol-3-yl]pyrimidin-2-yl]-3-methyl-1,4-diazepan-1-yl]butoxy]-1,2,3-triazol-1-yl]-3-methyl-butanoyl]-N-[(1R)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]-2-oxidanyl-ethyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · chains A, F
  • ZN · Zinc ion · metal · 2 copies · chains E

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111680.810.8283empty
211360.760.7887empty
31080.710.9224empty
43240.690.8344GDP
55450.650.7755empty

Interfaces

7 interfaces between chains.

  • D–E · 1861 Ų buried · 22 hydrogen bonds · protein-protein
  • B–C · 1090 Ų buried · 7 hydrogen bonds · protein-protein
  • A–C · 1039 Ų buried · 4 hydrogen bonds · protein-protein
  • C–D · 920 Ų buried · 8 hydrogen bonds · protein-protein
  • A–D · 223 Ų buried · 0 hydrogen bonds · protein-protein

Compared structures

  • P40337 · AlphaFold monomer V2.0 prediction for von hippel-lindau disease tumor suppressor (P40337) · a predicted model of the same protein · chain A against A, TM-score 0.95
  • P01116 · AlphaFold monomer V2.0 prediction for GTPase KRAS (P01116) · a predicted model of the same protein · chain F against A, TM-score 0.95
  • Q15369 · AlphaFold monomer V2.0 prediction for elongin-C (Q15369) · a predicted model of the same protein · chain C against A, TM-score 0.94
  • Q15370 · AlphaFold monomer V2.0 prediction for elongin-B (Q15370) · a predicted model of the same protein · chain B against A, TM-score 0.93
  • Q13617 · AlphaFold monomer V2.0 prediction for cullin-2 (Q13617) · a predicted model of the same protein · chain D against A, TM-score 0.90
  • P62877 · AlphaFold monomer V2.0 prediction for E3 ubiquitin-protein ligase RBX1 (P62877) · a predicted model of the same protein · chain E against A, TM-score 0.43

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.